Stocks Hitting 52-Week Lows

LeapFrog Enterprises

shares reached a new 52-week low of $6.305 after the company reported Q4 results. The Medicines Company

shares touched a new 52-week low of $28.47 after the company reported that the FDA CRDAC voted to recommend against approval of Cangrelor. Analysts at Credit Suisse downgraded the stock from Outperform to Neutral and lowered the target price from $45 to $35. Itron

shares declined 16.13% to touch a new 52-week low of $32.87 after the company reported Q4 results and authorized a $50 million buyback plan. Analysts at JP Morgan downgraded the stock from Neutral to Underweight and cut the price target from $41 to $30. Fairway Group Holdings

shares reached a new 52-week low of $7.53. Fairway Group's PEG ratio is -0.10.